CG
PTPI

Cutler Group’s Petros Pharmaceuticals PTPI Stock Holding History

Cutler Group’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 5381
2022
Q2 		– Sell
-2
Closed -$501 – 5517
2022
Q1 		$0 Buy
+2
New +$843 ﹤0.01% 5885
2021
Q2 		– Sell
-1
Closed -$1K – 6202
2021
Q1 		$1K Hold
1
– – ﹤0.01% 5330
2020
Q4 		$1K Buy
+1
New +$941 ﹤0.01% 4513

Other funds holding PTPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cutler Group's PTPI Position: Q3 2022 in Review

Cutler Group held its Petros Pharmaceuticals (PTPI) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5381.

Cutler Group first reported a position in PTPI in Q4 2020 and has held it in 3 quarters since. The position peaked at $1K in Q1 2021. 11 funds tracked by Wall St. Rank hold PTPI as of Q3 2022.

  • Cutler Group held 0 shares of Petros Pharmaceuticals worth $0 as of Q3 2022.
  • Cutler Group left its Petros Pharmaceuticals share count unchanged in Q3 2022.
  • Petros Pharmaceuticals made up ﹤0.01% of Cutler Group's portfolio in Q3 2022, its #5381 holding.
  • Cutler Group first reported a position in Petros Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • Cutler Group's Petros Pharmaceuticals position peaked at $1K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.